Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $33.60 ($134,387)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale COO, CFO sold 4,500 shares at $33.75 ($151,875)
  10. 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
  11. 4 Open-market sale Director sold 5,100 shares at $35.80 ($182,580)
  12. 4 Open-market sale Director sold 3,900 shares at an average $32.55 ($126,935)
  13. 4 Open-market sale Director sold 16,005 shares at an average $35.79 ($572,868)
  14. 4 Open-market sale Director sold 44,780 shares at an average $35.92 ($1,608,560)
  15. 4 Open-market sale President and CEO sold 14,000 shares at an average $35.65 ($499,096)
  16. 4 Open-market sale Director sold 3,500 shares at an average $34.51 ($120,768)
  17. 4 Open-market sale Director sold 1,787 shares at $35.67 ($63,742)
  18. 4 Other disposition 10% owner disposed of 505,000 shares (other)
  19. 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $34.83 ($139,309)
  20. 4 Open-market sale Director sold 600 shares at $35.64 ($21,384)

Page 7 of 10 · 190 filings